Clinical Trial Update: Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates [Phase 2]

View source ↗

Summary

Phase 2 trial update of denosumab (AMG 162) in patients with advanced cancer and bone metastases who were receiving IV bisphosphonates; results were posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castration-resistant Prostate Cancer
• Multiple Myeloma

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Bone Metastases in Men With Hormone-Refractory Prostate Cancer, Bone Metastases in Subjects With Advanced Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-01-07